HARRIS CASSANDRA
Known title: SVP Finance & CFOCIK: 0001770776
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Genesco sees mixed retail sector backdrop. Recent headlines show varied results across the retail sector. Stitch Fix shares dropped 18% even though its Q4 loss narrowed and revenue rose. Fossil Group is reported as lagging its peers, while Five Below is investing in digital marketing and personalization, and Wolverine reported gains from Merrell and Saucony. These developments highlight the competitive pressures and growth strategies that Genesco may also face in its own retail‑wholesale business.
Transaction History
| ESTA | ▲ Buy | Grant | 7,372 | $0 | 3/9/2026 | View on chart |
| GCO | ▼ Sell | Tax Withholding | 1,296 | $39K | 10/1/2025 | View on chart |
| GCO | ▲ Buy | Grant | 14,960 | $0 | 4/4/2025 | View on chart |
| GCO | ▲ Buy | Grant | 10,644 | $0 | 10/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ESTA Receives FDA Approval for New Motiva Implant Sizes
Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.
ESTA Receives FDA Approval for New Motiva Implant Sizes. Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.